Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC57H55Cl2F6N7O8 |
InChIKeyBCMRBUQELZGQDK-ZAZFVFGXSA-N |
CAS Registry2306388-85-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 12 Apr 2019 | |
Neoplasms | Preclinical | CN | 12 Apr 2019 |